Lorusso, Domenica

Lorusso, Domenica  

Dipartimento Scienze Biomediche  

Mostra records
Risultati 1 - 20 di 392 (tempo di esecuzione: 0.019 secondi).
Titolo Data di pubblicazione Autore(i) File
"Tumori della vulva e della vagina" 1-gen-2013 Lorusso, D
3D vision improves outcomes in early cervical cancer treated with laparoscopic type B radical hysterectomy and pelvic lymphadenectomy 1-gen-2017 Raspagliesi, F; Bogani, G; Martinelli, F; Signorelli, M; Scaffa, C; Sabatucci, I; Lorusso, D; Ditto, A
[Clinical applications of bevacizumab in the treatment of colorectal and ovarian cancer.] 1-gen-2021 Danesi, R.; Cremolini, C.; Ciccarone, F.; Lorusso, D.
A critical assessment on the role of sentinel node mapping in endometrial cancer 1-gen-2015 Bogani, G; Ditto, A; Martinelli, F; Signorelli, M; Perotto, S; Lorusso, D; Raspagliesi, F
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 1-gen-2022 Bartoletti, Michele; Bergamini, Alice; Giannone, Gaia; Nero, Camilla; Musacchio, Lucia; Farolfi, Alberto; Passarelli, Anna; Kuhn, Elisabetta; Castaldo, Daniele; Lombardo, Valentina; Di Palma, Teresa; Lorusso, Domenica; Puglisi, Fabio; De Giorgi, Ugo; Valabrega, Giorgio; Schettino, Clorinda; Scambia, Giovanni; Capoluongo, Ettore; Pignata, Sandro
A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: A pilot study 1-gen-2006 Fagotti, Anna; Ferrandina, Gabriella; Fanfani, Francesco; Ercoli, Alfredo; Lorusso, D; Rossi, Marco; Scambia, Giovanni
A multicentre phase 2 study of carboplatin (C) plus pegylated liposomal doxorubicin (PLO) as first-line chemotherapy for patients (pts) with advanced or recurrent endometrial carcinoma (AEC): The END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer) Group 1-gen-2006 Lorusso, D; Pignata, S.; Scambia, G.; Zagonel, V.; Riva, N.; Febbraro, A.; Pisano, C.; Greggi, S.; Breda, E.; Morabito, A.
A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group 1-gen-2007 Pignata, S.; Scambia, G.; Pisano, C.; Breda, E.; Di Maio, M.; Greggi, S.; Ferrandina, G.; Lorusso, D; Zagonel, V.; Febbraro, A.; Riva, N.; De Rosa, V.; Gallo, C.; Perrone, F.
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04) 1-gen-2024 Salani, Ritu; Mccormack, Mary; Kim, Yong-Man; Ghamande, Sharad; Hall, Shaundra L.; Lorusso, Domenica; Barraclough, Lisa; Gilbert, Lucy; Guzman Ramirez, Adrian; Lu, Chien-Hsing; Sabatier, Renaud; Colombo, Nicoletta; Hu, Youyou; Krishnan, Venkatesh; Molinero, Luciana; Feng, Yuning; Kim, Nicole; Castro, Marcela; Lin, Yvonne G.; Monk, Bradley J.; Foote, Janie
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy 1-gen-2011 Pignata, S.; Amant, F.; Scambia, G.; Sorio, R.; Breda, E.; Rasch, W.; Hernes, K.; Pisano, C.; Leunen, K.; Lorusso, D; Cannella, L.; Vergote, I.; Pignata, S.; Amant, F.; Scambia, G.; Sorio, R.; Breda, E.; Rasch, W.; Hernes, K.; Pisano, C.; Leunen, K.; Lorusso, D; Cannella, L.; Vergote, I.
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma 1-gen-2018 Gadducci, A; Grosso, F; Scambia, G; Raspagliesi, F; Colombo, N; Grignani, G; Casali, P; Sanfilippo, R; Buonadonna, A; Santoro, A; Bruzzone, M; Artioli, G; Lorusso, D; Biagioli, E; Fossati, R; Galli, F; Negri, E; Rulli, E; Torri, V; D’Incalci, M
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer - A Multicentre Italian Trial in Ovarian cancer (MITO-5) study 1-gen-2008 Pignata, Sandro; Breda, Enrico; Scambia, Giovanni; Pisano, Carmela; Zagonel, Vittorina; Lorusso, D; Greggi, Stefano; De Vivo, Rocco; Ferrandina, Gabriella; Gallo, Ciro; Perrone, Francesco
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms 1-gen-2019 Harter, P; Sehouli, J; Lorusso, D; Reuss, A; Vergote, I; Marth, C; Kim, Jw; Raspagliesi, F; Lampe, B; Aletti, G; Meier, W; Cibula, D; Mustea, A; Mahner, S; Runnebaum, Ib; Schmalfeldt, B; Burges, A; Kimmig, R; Scambia, G; Greggi, S; Hilpert, F; Hasenburg, A; Hillemanns, P; Giorda, G; von Leffern, I; Schade-Brittinger, C; Wagner, U; du Bois, A.
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45) 1-gen-2022 Monk, Bradley J.; Parkinson, Christine; Lim, Myong Cheol; O'Malley, David M.; Oaknin, Ana; Wilson, Michelle K.; Coleman, Robert L.; Lorusso, Domenica; Bessette, Paul; Ghamande, Sharad; Christopoulou, Athina; Provencher, Diane; Prendergast, Emily; Demirkiran, Fuat; Mikheeva, Olga; Yeku, Oladapo; Chudecka-Glaz, Anita; Schenker, Michael; Littell, Ramey D.; Safra, Tamar; Chou, Hung-Hsueh; Morgan, Mark A.; Drochýtek, Vít; Barlin, Joyce N.; Van Gorp, Toon; Ueland, Fred; Lindahl, Gabriel; Anderson, Charles; Collins, Dearbhaile C.; Moore, Kathleen; Marme, Frederik; Westin, Shannon N.; Mcneish, Iain A.; Shih, Danny; Lin, Kevin K.; Goble, Sandra; Hume, Stephanie; Fujiwara, Keiichi; Kristeleit, Rebecca S.
A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses 1-gen-2018 Bogani, G; Tagliabue, E; Signorelli, M; Ditto, A; Martinelli, F; Chiappa, V; Mosca, L; Sabatucci, I; Leone Roberti Maggiore, U; Lorusso, D; Raspagliesi, F.
A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer 1-gen-2014 Lorusso, D; Petrelli, F; Coinu, A; Raspagliesi, F; Barni, S
A Treatment Selection Protocol for Recurrent Ovarian Cancer Patients: The Role of FDG-PET/CT and Staging Laparoscopy 1-gen-2008 Fagotti, A.; Fanfani, F.; Rossitto, C.; Lorusso, D; De Gaetano, A. M.; Giordano, A.; Vizzielli, G.; Scambia, G.
Accuracy of pre-operative hysteroscopic guided biopsy for predicting final pathology in uterine malignancies 1-gen-2017 Martinelli, Fabio; Ditto, Antonino; Bogani, Giorgio; Signorelli, Mauro; Chiappa, Valentina; Lorusso, Domenica; Haeusler, Edward; Raspagliesi, Francesco
Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment 1-gen-2021 Nero, C; Ciccarone, F; Pietragalla, A; Duranti, S; Daniele, G; Scambia, G; Lorusso, D
Adoptive immunotherapy with cytokine-induced killer cells generated with a new GMP-grade protocol 1-gen-2012 Rutella, S.; Bonanno, G.; Iudicone, P.; Fioravanti, D.; Procoli, A.; Lavorino, C.; Foddai, M. L.; Lorusso, D; Bertaina, A.; Vacca, M.; Ipsevich, F.; Nuti, M.; Scambia, G.; Pierelli, L.